Cancers (Mar 2022)

Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives

  • Asad Ullah,
  • Jaffar Khan,
  • Abdul Waheed,
  • Nitasha Sharma,
  • Elizabeth K. Pryor,
  • Tanner R. Stumpe,
  • Luis Velasquez Zarate,
  • Frederick D. Cason,
  • Suresh Kumar,
  • Subhasis Misra,
  • Sravan Kavuri,
  • Hector Mesa,
  • Nitin Roper,
  • Shahin Foroutan,
  • Nabin Raj Karki,
  • Jaydira Del Rivero,
  • William F. Simonds,
  • Nagla Abdel Karim

DOI
https://doi.org/10.3390/cancers14061426
Journal volume & issue
Vol. 14, no. 6
p. 1426

Abstract

Read online

Introduction: Parathyroid carcinoma (PC) is an extremely rare entity, with a frequency of 0.005% of all malignancies. Most data related to this rare disease are limited to case series and a few database studies. We present a large database study that aims to investigate the demographic, clinical, and pathological factors, prognosis, and survival of PC. Methods: Data of parathyroid carcinoma were extracted from the Surveillance, Epidemiology, and End Results (SEER) diagnosed between 1975 and 2016. Results: PC had a slightly higher incidence in men (52.2%, p p p p p p p p 4 cm, age > 40 years, male sex, Caucasian race, distant spread, and poorly differentiated grade as independent risk factors for mortality (p < 0.001). Conclusion: PC is a very rare tumor mostly affecting Caucasian individuals in the fifth decade. Older age, poor histologic differentiation, and distant metastasis are associated with a worse prognosis. Surgical resection offers the best survival outcome. To better understand the pathogenesis and factors affecting survival, all PC patients should be enrolled in national and international registries.

Keywords